Suppr超能文献

血浆 IL-12/IFN-γ 轴可预测认知正常老年人的认知轨迹。

Plasma IL-12/IFN-γ axis predicts cognitive trajectories in cognitively unimpaired older adults.

机构信息

Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.

Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.

出版信息

Alzheimers Dement. 2022 Apr;18(4):645-653. doi: 10.1002/alz.12399. Epub 2021 Jun 23.

Abstract

INTRODUCTION

Immune dysregulation is implicated in neurodegeneration and altered cytokine levels are seen in people with dementia. However, whether cytokine levels are predictive of cognitive decline in cognitively unimpaired (CU) elderly, especially in the setting of elevated amyloid beta (Aβ), remains unclear.

METHODS

We measured nine cytokines in the baseline plasma of 298 longitudinally followed CU elderly and assessed whether these measures were associated with cognitive decline, alone or synergistically with Aβ. We next examined associations between cytokine levels and neuroimaging biomarkers of Aβ/tau/neurodegeneration.

RESULTS

Higher IL-12p70 was associated with slower cognitive decline in the setting of higher Aβ (false discovery rate [FDR] = 0.0023), whereas higher IFN-γ was associated with slower cognitive decline independent of Aβ (FDR = 0.013). Higher IL-12p70 was associated with less tau and neurodegeneration in participants with higher Aβ.

DISCUSSION

Immune dysregulation is implicated in early-stage cognitive decline, and greater IL-12/IFN-γ axis activation may be protective against cognitive decline and early-stage AD progression.

摘要

简介

免疫失调与神经退行性变有关,痴呆患者的细胞因子水平发生改变。然而,细胞因子水平是否可预测认知功能正常(CU)老年人的认知能力下降,特别是在淀粉样蛋白β(Aβ)水平升高的情况下,尚不清楚。

方法

我们测量了 298 名纵向随访的 CU 老年人基线血浆中的 9 种细胞因子,并评估了这些指标是否与认知能力下降有关,是否与 Aβ 协同作用。接下来,我们检查了细胞因子水平与 Aβ/tau/神经退行性变的神经影像学生物标志物之间的关联。

结果

在 Aβ 水平较高的情况下,IL-12p70 较高与认知下降速度较慢有关(假发现率 [FDR] = 0.0023),而 IFN-γ 较高与 Aβ 独立的认知下降速度较慢有关(FDR = 0.013)。在 Aβ 水平较高的参与者中,较高的 IL-12p70 与较少的 tau 和神经退行性变有关。

讨论

免疫失调与认知能力下降的早期阶段有关,IL-12/IFN-γ 轴的激活增强可能对认知能力下降和早期 AD 进展具有保护作用。

相似文献

1
Plasma IL-12/IFN-γ axis predicts cognitive trajectories in cognitively unimpaired older adults.
Alzheimers Dement. 2022 Apr;18(4):645-653. doi: 10.1002/alz.12399. Epub 2021 Jun 23.
5
Tau Mediates Synergistic Influence of Vascular Risk and Aβ on Cognitive Decline.
Ann Neurol. 2022 Nov;92(5):745-755. doi: 10.1002/ana.26460. Epub 2022 Aug 13.
6
Difference in trajectories according to early amyloid accumulation in cognitively unimpaired elderly.
Eur J Neurol. 2024 Dec;31(12):e16482. doi: 10.1111/ene.16482. Epub 2024 Sep 14.
8
Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
J Neurosci. 2019 Sep 11;39(37):7428-7437. doi: 10.1523/JNEUROSCI.1056-19.2019. Epub 2019 Jul 26.
9
Association of CSF GAP-43 With the Rate of Cognitive Decline and Progression to Dementia in Amyloid-Positive Individuals.
Neurology. 2023 Jan 17;100(3):e275-e285. doi: 10.1212/WNL.0000000000201417. Epub 2022 Oct 3.

引用本文的文献

1
Sex differences and the role of estrogens in the immunological underpinnings of Alzheimer's disease.
Alzheimers Dement (N Y). 2025 Aug 17;11(3):e70139. doi: 10.1002/trc2.70139. eCollection 2025 Jul-Sep.
6
Rapamycin treatment for Alzheimer's disease and related dementias: a pilot phase 1 clinical trial.
Commun Med (Lond). 2025 May 20;5(1):189. doi: 10.1038/s43856-025-00904-9.
7
A 3D human iPSC-derived multi-cell type neurosphere system to model cellular responses to chronic amyloidosis.
J Neuroinflammation. 2025 Apr 24;22(1):119. doi: 10.1186/s12974-025-03433-3.
8
Analysis and interpretation of inflammatory fluid markers in Alzheimer's disease: a roadmap for standardization.
J Neuroinflammation. 2025 Apr 15;22(1):105. doi: 10.1186/s12974-025-03432-4.
10
Targeting Myeloperoxidase to Reduce Neuroinflammation in X-Linked Dystonia Parkinsonism.
CNS Neurosci Ther. 2024 Nov;30(11):e70109. doi: 10.1111/cns.70109.

本文引用的文献

3
Multicenter Alzheimer's and Parkinson's disease immune biomarker verification study.
Alzheimers Dement. 2020 Feb;16(2):292-304. doi: 10.1016/j.jalz.2019.07.018. Epub 2020 Jan 6.
4
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies.
Cell. 2019 Oct 3;179(2):312-339. doi: 10.1016/j.cell.2019.09.001. Epub 2019 Sep 26.
6
The gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk.
Sci Transl Med. 2019 Aug 14;11(505). doi: 10.1126/scitranslmed.aau2291.
7
Inflammatory biomarkers in Alzheimer's disease plasma.
Alzheimers Dement. 2019 Jun;15(6):776-787. doi: 10.1016/j.jalz.2019.03.007. Epub 2019 Apr 30.
9
Inflammatory markers in Alzheimer's disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies.
J Neurol Neurosurg Psychiatry. 2019 May;90(5):590-598. doi: 10.1136/jnnp-2018-319148. Epub 2019 Jan 10.
10
Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE.
Nat Neurosci. 2019 Feb;22(2):191-204. doi: 10.1038/s41593-018-0296-9. Epub 2019 Jan 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验